RxDoctor Payments Data

Kelly Muench

Physician Assistant · Lancaster, WINPI 1699730861

Payments from drug & device makers

$2,924in general payments, 2019–2025

Across 176 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$567
  • Boehringer Ingelheim$374
  • Pfizer$317
  • Lilly USA, LLC$256
  • Johnson & Johnson$199
  • Novo Nordisk$182
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$2,924100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,924 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide57$69,575
JardianceEmpagliflozin42$37,962
XareltoRivaroxaban39$34,365
MounjaroTirzepatide21$20,876
FarxigaDapagliflozin Propanediol15$20,020
LinzessLinaclotide16$13,577
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog33$13,332
OzempicSemaglutide15$12,911
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,327
Spiriva RespimatTiotropium Bromide11$8,802
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$8,582
Incruse ElliptaUmeclidinium Bromide16$5,612
Insulin Lispro Kwikpen U-100Insulin Lispro19$3,520
Gabapentin62$1,635
Metoprolol Succinate84$1,569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$256$90,45178 claims
Boehringer IngelheimJardiance, Spiriva Respimat$374$46,76453 claims
Johnson & JohnsonXarelto$199$34,36539 claims
GSKTrelegy Ellipta, Incruse Ellipta$28$14,93930 claims
AbbVieLinzess$567$13,57716 claims
Novo NordiskOzempic$182$12,91115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Lancaster

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →